Navigation Links
Cynvec LLC(SM) to Present at the Cowen and Company 29th Annual Health Care Conference
Date:3/9/2009

NEW YORK, March 9 /PRNewswire/ -- Cynvec LLC, a privately held biotechnology company focused on developing novel cancer therapies that harness the apoptotic ability of the sindbis viral vector, today announced that Frank Stonebanks, President and Chief Executive Officer, will present at the Cowen and Company 29th Annual Health Care Conference in Boston on Monday, March 16, 2009 at 4:00 p.m. ET.

About Cynvec LLC

Cynvec, a privately held biotechnology company, is developing proprietary cancer therapies based on the apoptotic sindbis oncolytic viral vector, a novel technology that targets overexpressed laminin receptors on the surface of many solid tumors without affecting normal cells. Under an exclusive worldwide license from the NYU School of Medicine, Cynvec is developing therapies that may be used as a single agent or in combination with cytotoxics, monoclonal antibodies, chemotherapeutic agents and radiation. The company's lead product, CYN 101, has shown tumor eradication and highly significant survival rates in pre-clinical models of ovarian and pancreatic cancer as both a single agent and in combination with licensed chemotherapies. Cynvec is also developing a companion vector that will provide an in vivo, quantitative, real time cancer diagnostic. Cynvec expects to begin Phase I clinical trials of CYN 101 in ovarian cancer in the third quarter of 2009. The sindbis vector has also demonstrated in vivo efficacy delivering a variety of cytokines directly to tumor sites. Additionally, a screening program is underway to identify small molecules that bind to the laminin receptor, which is implicated in Alzheimer's disease, multiple sclerosis and Parkinson's. Further information on Cynvec can be found at www.cynvec.com.


'/>"/>
SOURCE Cynvec LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cynvec LLC(SM) to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008
2. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
3. Repligen to Present at the Cowen and Company 29th Annual Healthcare Conference Monday, March 16th, 2:25 p.m. EDT
4. Peregrine Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
5. Micromet to Present at the Cowen Health Care Conference on March 17, 2009
6. Schering-Plough to Webcast Presentation at Barclays Capital Global Healthcare Conference
7. Gen-Probe to Webcast Two Upcoming Investor Presentations
8. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
9. Micell Technologies Rapid Absorption Polymer DES System to be Presented at CRT 2009
10. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
11. Infectious Diseases Company, Sequella, to Present at Upcoming European Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... , ... Global Stem Cells Group CEO Benito Novas announced that ... GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in ... hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM Professor ...
(Date:4/26/2016)... , ... April 26, 2016 , ... ... announced that Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, ... bringing innovative genomic technologies to market, was most recently Chief Commercial Officer of ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., ... A round of financing. Healthy investor interest drove significant oversubscription of the original ... biologics, known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and ...
(Date:4/26/2016)... 26, 2016 genae, a Contract ... industries, announced today the appointment of Prof. Dr. Jörn ... Balzer,s responsibilities will include all clinical, safety and risk ... feel privileged and honored with the acceptance of Prof. ... , CEO at genae. "Prof. Balzer,s impressive and extensive ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):